Evidence map

ArticleJournal of diabetes investigation2025

Effectiveness for adding or switching from other incretin-related drugs to oral semaglutide in type 2 diabetes.

Junko Oya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39707717